Characteristics of Patients With Chronic Hepatitis B Virus Infection With Genotype E Predominance in Burkina Faso.
Characteristics of Patients With Chronic Hepatitis B Virus Infection With Genotype E Predominance in Burkina Faso.
复制标题
DOI:
10.1002/hep4.1595
复制
发表时间:
2020-12
影响因子:
5.1
通讯作者:
Roberts LR
中科院分区:
文献类型:
--
作者:
Wongjarupong N;Yonli AT;Nagalo BM;Djigma FW;Somda SK;Hassan MA;Mohamed EA;Sorgho AP;Compaore TR;Soubeiga ST;Kiendrebeogo I;Sanou M;Diarra B;Yang HI;Chen CJ;Ouattara AK;Zohoncon TM;Martinson JJ;Buetow K;Chamcheu JC;Antwi SO;Borad MJ;Simpore J;Roberts LR
Hepatitis B virus (HBV) genotype E (HBV‐E) accounts for the majority of chronic hepatitis B (CHB) infections in West Africa. We aimed to determine factors associated with HBV‐E‐induced hepatocellular carcinoma (HCC) in West Africa. Data on patients from Burkina Faso who were hepatitis B surface antigen positive (HBsAg+) and had CHB were analyzed. HBV viral load and hepatitis B e antigen (HBeAg) status were measured in 3,885 individuals with CHB without HCC (CHB HCC−) and 59 individuals with CHB with HCC (CHB HCC+). HBV genotyping was performed for 364 subjects with CHB HCC− and 41 subjects with CHB HCC+. Overall, 2.5% of the CHB HCC− group was HBeAg+ compared with 0% of the CHB HCC+ group. Of the 364 patients who were CHB HCC− with available genotyping, the frequencies of HBV genotypes E and C/E were 70.3% and 12.9%, respectively. Age (odds ratio [OR] for older age, 1.08; 95% confidence interval [CI], 1.06‐1.10 per 1‐year increase in age), male sex (OR, 2.03; 95% CI, 1.11‐3.69), and HBV viremia (OR, 1.48; 95% CI, 1.31‐1.67 per 1 log10 IU/mL) were each associated with HCC diagnosis. Patients with genotype E had a lower HBeAg prevalence (6.3% vs. 14.9%), lower HBV viral load, and higher prevalence of cirrhosis (14.5% vs. 4.8%) than patients with genotype C/E. Conclusion: HBV‐E is the most common circulating strain (70.3%) in West African patients. HCC was associated with older age, male sex, and high HBV viral load. It is expected that these results will further inform guidance on clinical management of HBV infection in West Africa.
登录
查看更多内容
影响因子:
120.7
作者:
Chen, CJ;Yang, HI;Iloeje, UH
通讯作者:
Iloeje, UH
影响因子:
5.1
作者:
Nelson NP;Easterbrook PJ;McMahon BJ
通讯作者:
McMahon BJ
影响因子:
3.7
作者:
Malagnino, Vincenzo;Salpini, Romina;Sarmati, Loredana
通讯作者:
Sarmati, Loredana
影响因子:
5
作者:
Martinson, FEA;Weigle, KA;Lemon, SM
通讯作者:
Lemon, SM
影响因子:
2.4
作者:
Schlabe S;van Bremen K;Aldabbagh S;Glebe D;Bremer CM;Marsen T;Mellin W;Cristanziano VD;Eis-Hübinger AM;Spengler U
通讯作者:
Spengler U